High levels of ROS are major factors in immune-suppression and inhibition for T cell activation and proliferation, while low levels of ROS generate T cell activation in the TME, whereas CAFs have been implicated in immune-suppression of CD8+ T cells in GBM. The gene discussed is CD8A; the disease is glioblastoma.